Evidence map›Paper›PMID 27039093›Full record

ArticleEuropean journal of nutrition2017

A specific dose of grape seed-derived proanthocyanidins to inhibit body weight gain limits food intake and increases energy expenditure in rats.

Joan Serrano, Àngela Casanova-Martí, Andreu Gual, Anna Maria Pérez-Vendrell, M Teresa Blay, Ximena Terra, Anna Ardévol, Montserrat Pinent

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Proanthocyanidin-Rich Cranberry Extract Lowers Glycemia in Established Obesity by Delaying Glucose Absorption.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Effect of Trilobatin fromNutrients · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Joan SerranoDepartament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, c/Marcel·lí Domingo, No. 1, 43007, Tarragona, Spain.
Àngela Casanova-MartíDepartament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, c/Marcel·lí Domingo, No. 1, 43007, Tarragona, Spain.
Andreu GualDepartament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, c/Marcel·lí Domingo, No. 1, 43007, Tarragona, Spain.
Anna Maria Pérez-VendrellMonogastric Nutrition, Centre Mas de Bover, IRTA, Ctra. Reus-El Morell Km 3.8, 43120, Constantí, Spain.
M Teresa BlayDepartament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, c/Marcel·lí Domingo, No. 1, 43007, Tarragona, Spain.
Ximena TerraDepartament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, c/Marcel·lí Domingo, No. 1, 43007, Tarragona, Spain.
Anna ArdévolDepartament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, c/Marcel·lí Domingo, No. 1, 43007, Tarragona, Spain. anna.ardevol@urv.cat.
Montserrat PinentDepartament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, c/Marcel·lí Domingo, No. 1, 43007, Tarragona, Spain.
Universidad Rovira i Virgili · ESInstitute for Research and Technology in Food and Agriculture · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSeveral studies have suggested that flavanols may have antiobesity effects; however, those effects clearly depend on the experimental conditions. In a previous study, we found that a single acute dose of grape seed proanthocyanidin extract (GSPE) has satiating effects. We therefore hypothesise that satiating doses of GSPE could be used to reduce body weight gain, and our present objective was to define the most effective dose.

methodsWe assayed two GSPE doses in aged male Wistar rats. First we performed a subchronic (8-day) treatment by intragastric administration, which was repeated after a washout period. We measured body weight, energy intake and faeces composition; we performed indirect calorimetry; and we analysed the mRNA expression of genes involved in lipid metabolism to determine the target tissue for the GSPE.

resultsWe observed that 0.5 g GSPE/kg BW significantly reduced food intake and thus the amount of energy absorbed. This dosage also increased lipid oxidation in subcutaneous adipose tissue, thus causing a higher total energy expenditure. These combined effects caused a decrease in body weight. Conversely, 1 g GSPE/kg BW, which also reduced energy absorption after the first treatment, had a rebound effect on body weight gain which resulted in a lower response to the proanthocyanidin extract. That is, after the second treatment, the GSPE did not reduce the energy absorbed or modify energy expenditure and body weight.

conclusionGSPE at a dose of 0.5 g/kg can reduce body weight by limiting food intake and activating energy expenditure in subcutaneous adipose tissue.

Indexed as

AnimalsAnti-Obesity AgentsAntioxidantsBody WeightDose-Response Relationship, DrugEatingEnergy MetabolismGrape Seed ExtractLipid MetabolismMaleProanthocyanidinsRatsRats, WistarWeight GainAnti-Obesity AgentsAntioxidantsGrape Seed ExtractGrape Seed ProanthocyanidinsProanthocyanidinsEnergy expenditureFood intakeObesityProanthocyanidinSubcutaneous adipose tissue

Identifiers

PMID27039093
OpenAlexW2326604966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.